Last updated: 4 February 2020 at 11:02am EST

Doug Alleavitch Net Worth




The estimated Net Worth of Doug Alleavitch is at least $2.35 million dollars as of 25 November 2019. Doug Alleavitch owns over 1,000 units of Nevro Corp stock worth over $113,384 and over the last 9 years Doug sold NVRO stock worth over $2,234,106.

Doug Alleavitch NVRO stock SEC Form 4 insiders trading

Doug has made over 19 trades of the Nevro Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently Doug sold 1,000 units of NVRO stock worth $110,000 on 25 November 2019.

The largest trade Doug's ever made was selling 3,000 units of Nevro Corp stock on 22 August 2016 worth over $300,000. On average, Doug trades about 1,076 units every 53 days since 2015. As of 25 November 2019 Doug still owns at least 24,073 units of Nevro Corp stock.

You can see the complete history of Doug Alleavitch stock trades at the bottom of the page.



What's Doug Alleavitch's mailing address?

Doug's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.

Insiders trading at Nevro Corp

Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo et & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.



What does Nevro Corp do?

headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.



Complete history of Doug Alleavitch stock trades at Nevro Corp

Initié
Trans.
Transaction
Prix ​​total
Doug Alleavitch
Vice-président et Quality
Vente $110,000
25 Nov 2019
Doug Alleavitch
Vice-président et Quality
Vente $100,000
7 Nov 2019
Doug Alleavitch
Vice-président et Quality
Exercice d'option $43,611
5 Mar 2019
Doug Alleavitch
Vice-président et Quality
Exercice d'option $53,700
1 Aug 2018
Doug Alleavitch
Vice-président et Quality
Exercice d'option $80,550
25 Jul 2018
Doug Alleavitch
Vice-président et Quality
Vente $300,000
22 Aug 2016
Doug Alleavitch
Vice-président et Quality
Vente $300,000
22 Aug 2016
Doug Alleavitch
Vice-président et Quality
Vente $237,500
10 Aug 2016
Doug Alleavitch
Vice-président et Quality
Vente $237,500
10 Aug 2016
Doug Alleavitch
Vice-président et Quality
Vente $85,000
29 Jul 2016
Doug Alleavitch
Vice-président et Quality
Vente $85,000
29 Jul 2016
Doug Alleavitch
Vice-président et Quality
Vente $160,000
11 Jul 2016
Doug Alleavitch
Vice-président et Quality
Vente $160,000
11 Jul 2016
Doug Alleavitch
Vice-président et Quality
Vente $75,000
8 Jun 2016
Doug Alleavitch
Vice-président et Quality
Vente $75,000
8 Jun 2016
Doug Alleavitch
Vice-président et Quality
Vente $36,000
1 Jun 2016
Doug Alleavitch
Vice-président et Quality
Vente $36,000
1 Jun 2016
Doug Alleavitch
Vice-président et Quality
Vente $70,000
11 Jan 2016
Doug Alleavitch
Vice-président et Quality
Vente $167,106
4 Jan 2016


Nevro Corp executives and stock owners

Nevro Corp executives and other stock owners filed with the SEC include: